Crossmark

Determination of novel CYP2D6 haplotype using the targeted sequencing followed by the long-read sequencing and the functional characterization in the Japanese population

Crossref DOI link: https://doi.org/10.1038/s10038-020-0815-x

Published Online: 2020-08-05

Published Print: 2021-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Fukunaga, Koya

Hishinuma, Eiji

Hiratsuka, Masahiro https://orcid.org/0000-0002-3767-7686
Kato, Ken https://orcid.org/0000-0002-1733-5072
Okusaka, Takuji https://orcid.org/0000-0003-1729-807X
Saito, Takeo

Ikeda, Masashi https://orcid.org/0000-0001-6237-2449
Yoshida, Teruhiko

Zembutsu, Hitoshi

Iwata, Nakao https://orcid.org/0000-0003-3189-6076
Mushiroda, Taisei
Funding

Funding for this research was provided by:

Japan Agency for Medical Research and Development (JP19km0405201)

Japan Agency for Medical Research and Development (JP19km0405201)

Japan Agency for Medical Research and Development (JP19kk0305009)

Japan Agency for Medical Research and Development (JP19kk0305009)

Japan Agency for Medical Research and Development (JP19km0405201)

Japan Agency for Medical Research and Development (JP19km0405201)

Japan Agency for Medical Research and Development (JP19km0405201)

Japan Agency for Medical Research and Development (JP19km0405201)

Japan Agency for Medical Research and Development (JP19km0405201)

Japan Agency for Medical Research and Development (JP19km0405201)

Japan Agency for Medical Research and Development (JP19km0405201)
License Information

Text and Data Mining valid from 2020-08-05

Version of Record valid from 2020-08-05
More Information

Article History

Received: 12 February 2020

Revised: 8 July 2020

Accepted: 26 July 2020

First Online: 5 August 2020

Compliance with ethical standards

:

: The authors declare that they have no conflict of interest.

Document is current

Any future updates will be listed below